Isotopes for Hope Podcast Canadian Nuclear Isotope Council

The Isotopes for Hope Podcast is a series that highlights Canadian leaders in the country's isotope and cancer care sector who are contributing to Canada's leadership role in fighting cancer. While this podcast aims to frame the industry’s future in this area, we will also feature unique stories and perspectives about the importance of isotopes from current industry leaders.

In this episode, CNIC Chair James Scongack is joined by Dr. Jonathan Cirtain, Senior VP and Chief Development Officer of BWX Technologies (BWXT) and President & CEO of BWXT Medical Ltd. BWXT Medical is an experienced manufacturer and supplier of both isotope technologies and critical medical isotopes and radiopharmaceuticals for research, diagnostic and therapeutic use.

The Isotopes for Hope Podcast is a series that highlights Canadian leaders in the country's isotope and cancer care sector who are contributing to Canada's leadership role in fighting cancer. While this podcast aims to frame the industry’s future in this area, we will also feature unique stories and perspectives about the importance of isotopes from current industry leaders.

In this episode, CNIC Chair James Scongack is joined by Robert Kamen, founding President of South West Exposures (SWE). SWE is an industry leader in the shielding and packaging of medical isotopes for diagnostic and therapeutic applications, helping to make just-in-time delivery of isotopes safe and timely.

The Isotopes for Hope Podcast is a series that highlights Canadian leaders in the country's isotope and cancer care sector who are contributing to Canada's leadership role in fighting cancer. While this podcast aims to frame the industry’s future in this area, we will also feature unique stories and perspectives about the importance of isotopes from current industry leaders.

In this episode, CNIC Chair James Scongack is joined by Steffen Schuster, CEO of ITM Isotope Technologies Munich. Based in Germany but with multiple partnerships with Canadian companies like Bruce Power, IsoGen, and more recently Canadian Nuclear Laboratories through new venture Actineer, ITM is a global leader in the development, production and global supply of targeted diagnostic and therapeutic radioisotopes for use in cancer treatment.

The Isotopes for Hope Podcast is a series that highlights Canadian leaders in the country's isotope and cancer care sector who are contributing to Canada's leadership role in fighting cancer. While this podcast aims to frame the industry’s future in this area, we will also feature unique stories and perspectives about the importance of isotopes from current industry leaders.

In this episode, CNIC Chair James Scongack is joined by Dr. Karin Stephenson, Director of Research and Education support for Nuclear Operations and Facilities at McMaster University. McMaster University is home to Canada's most powerful neutron source, and is a global leader in the production of iodine-125 and holmium-166, used to treat cancer patients around the world.

The Isotopes for Hope Podcast is a series that highlights Canadian leaders in the country's isotope and cancer care sector who are contributing to Canada's leadership role in fighting cancer. While this podcast aims to frame the industry’s future in this area, we will also feature unique stories and perspectives about the importance of isotopes from current industry leaders.

In this episode, CNIC Chair James Scongack is joined by David Harris, President & CEO of Kinectrics, and Dr. Travis Besanger, Senior Business & Technical Director of Medical Isotopes at Kinectrics. Kinectrics and Framatome together form a joint venture called IsoGen that has implemented an Isotope Production System at Bruce Power. The IPS is the world’s first commercial scale source of lutetium-177 produced by a power reactor and the first commercial stable isotope enrichment platform for the production of ytterbium-176 in North America.

The Isotopes for Hope Podcast is a series that highlights Canadian leaders in the country's isotope and cancer care sector who are contributing to Canada's leadership role in fighting cancer. While this podcast aims to frame the industry’s future in this area, we will also feature unique stories and perspectives about the importance of isotopes from current industry leaders.

In this episode, CNIC Chair James Scongack is joined by Dr. Arjun Sahgal, Chief of the Department of Radiation Oncology at the University of Toronto Sunnybrook Odette Cancer Centre, and Shannon LaHay, CEO of the Brain Tumour Foundation of Canada. Join us for a conversation about how isotope are used to diagnose and treat brain tumours and brain metastases, offering promising results for patients.